You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Travelers Companies, Inc. (TRV) - free report >>
Guess?, Inc. (GES) - free report >>
Par Pacific Holdings, Inc. (PARR) - free report >>
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) - free report >>
Image: Bigstock
New Strong Buy Stocks for Oct. 23: MQ, GES and More
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Marqeta, Inc. (MQ - Free Report) : This card issuing platform has seen the Zacks Consensus Estimate for its current year earnings increasing 42.9% over the last 60 days.
Marqeta, Inc. Price and Consensus
Marqeta, Inc. price-consensus-chart | Marqeta, Inc. Quote
Guess?, Inc. (GES - Free Report) : This apparel and accessories company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Guess?, Inc. Price and Consensus
Guess?, Inc. price-consensus-chart | Guess?, Inc. Quote
The Travelers Companies, Inc. (TRV - Free Report) : This insurance services provider has seen the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.
The Travelers Companies, Inc. Price and Consensus
The Travelers Companies, Inc. price-consensus-chart | The Travelers Companies, Inc. Quote
Chemomab Therapeutics Ltd. (CMMB - Free Report) : This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 70% over the last 60 days.
Chemomab Therapeutics Ltd. Sponsored ADR Price and Consensus
Chemomab Therapeutics Ltd. Sponsored ADR price-consensus-chart | Chemomab Therapeutics Ltd. Sponsored ADR Quote
Par Pacific Holdings, Inc. (PARR - Free Report) : This energy and infrastructure business has seen the Zacks Consensus Estimate for its current year earnings increasing 100.6% over the last 60 days.
Par Pacific Holdings, Inc. Price and Consensus
Par Pacific Holdings, Inc. price-consensus-chart | Par Pacific Holdings, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.